))
Episode 30: A Between the Biotech Waves conversation with Barry Greene, CEO of Sage Therapeutics
Manage episode 370716629 series 3360242
Content provided by Nessan Bermingham PhD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Nessan Bermingham PhD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Today we are talking to Barry Greene, CEO of Sage Therapeutics. Barry has had an amazing career spanning over 30 years in the biotech industry. Prior to Sage Barry was President of Alnylam shepherding it with John through its evolution from basic science through commercial product launch. Prior to ALNY Barry was general manager of Oncology at Millennium where he was directly involved in the approval and launch of Velcade. He is currently a member of the board of the Pharmaceutical Research and Manufacturers of America.
43 episodes
Share
